Anti-inflammatory and immunosuppressive drugs and reproduction

Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus workshop of international experts discussing effects of anti-inflammatory, immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Østensen, Monika, Khamashta, Munther, Lockshin, Michael, Parke, Ann, Brucato, Antonio, Carp, Howard, Doria, Andrea, Rai, Raj, Meroni, Pierluigi, Cetin, Irene, Derksen, Ronald, Branch, Ware, Motta, Mario, Gordon, Caroline, Ruiz-Irastorza, Guillermo, Spinillo, Arsenio, Friedman, Deborah, Cimaz, Rolando, Czeizel, Andrew, Piette, Jean Charles, Cervera, Ricard, Levy, Roger A, Clementi, Maurizio, De Carolis, Sara, Petri, Michelle, Shoenfeld, Yehuda, Faden, David, Valesini, Guido, Tincani, Angela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526635/
https://www.ncbi.nlm.nih.gov/pubmed/16712713
http://dx.doi.org/10.1186/ar1957
Descripción
Sumario:Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus workshop of international experts discussing effects of anti-inflammatory, immunosuppressive and biological drugs during pregnancy and lactation. In addition, effects of these drugs on male and female fertility and possible long-term effects on infants exposed to drugs antenatally are discussed where data were available. Recommendations for drug treatment during pregnancy and lactation are given.

Ejemplares similares